ConductScience.org, home

Paper39083045

Mechanisms of a novel regulatory light chain-dependent cardiac myosin inhibitor.

Kooiker K and 15 others. J Gen Physiol, 2024. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Mechanisms of a novel regulatory light chain-dependent cardiac myosin inhibitor. Papers, record 39083045. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39083045

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Mechanisms of a novel regulatory light chain-dependent cardiac myosin inhibitor.
PubMed
Journal
J Gen Physiol
PubMed
Year
2024
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S., Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
2
iCite
Relative citation ratio, by iCite
0.26, provisional
iCite
Revised in PubMed
2026-04-08
PubMed

Authors16

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Myocardial ContractionMajor topic
Animals
Rats
Myosin Light Chains
Cattle
Myofibrils
Cardiac Myosins
Rats, Sprague-Dawley
Male
Calcium

Source PubMed

Download CSV of topics

Grants11

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
DE-AC02-06CH11357U.S. Department of EnergyPubMedPubMed
R01 HL157169NHLBI NIH HHSUnited StatesR01HL157169PubMed and NIHNIH RePORTER
P30 AR074990NIAMS NIH HHSUnited StatesP30AR074990PubMed and NIHNIH RePORTER
K08 HL128826NHLBI NIH HHSUnited StatesK08HL128826PubMed and NIHNIH RePORTER
R01 HL128368NHLBI NIH HHSUnited StatesR01HL128368PubMed and NIHNIH RePORTER
MyoKon 11456Bristol Myers SquibbPubMedPubMed
T32 EB032787NIBIB NIH HHSUnited StatesT32EB032787PubMedNIH RePORTER
R01 HL128368NIH HHSUnited StatesR01HL128368PubMed and NIHNIH RePORTER
P30 GM138395NIGMS NIH HHSUnited StatesP30GM138395PubMed and NIHNIH RePORTER
P30AR074990University of WashingtonP30AR074990PubMed and NIHNIH RePORTER
RM1GM131981NIHNIH RePORTER

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in39136654Novel cardiac myosin inhibitor for hypertrophic cardiomyopathy.https://conductscience.org/library/papers/39136654

Source PubMed

Download CSV of comments and corrections

References38

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123629510Contractility and kinetics of human fetal and human adult skeletal muscle.J Physiol2013https://conductscience.org/library/papers/23629510PubMed
24254541The regulation of rabbit skeletal muscle contraction. I. Biochemical studies of the interaction of the tropomyosin-troponin complex with actin and the proteolytic fragments of myosin.J Biol Chem1971https://conductscience.org/library/papers/4254541PubMed
334117120Hypertrophic cardiomyopathy β-cardiac myosin mutation (P710R) leads to hypercontractility by disrupting super relaxed state.Proc Natl Acad Sci U S A2021https://conductscience.org/library/papers/34117120PubMed
47121269Purification of muscle actin.Methods Enzymol1982https://conductscience.org/library/papers/7121269PubMed
526912705A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice.Science2016https://conductscience.org/library/papers/26912705PubMed
620123786Differential roles of regulatory light chain and myosin binding protein-C phosphorylations in the modulation of cardiac force development.J Physiol2010https://conductscience.org/library/papers/20123786PubMed
738494592Mechanistic basis for rescuing hypertrophic cardiomyopathy with myosin regulatory light chain phosphorylation.Cytoskeleton (Hoboken)2024https://conductscience.org/library/papers/38494592PubMed
833449850Mavacamten preserves length-dependent contractility and improves diastolic function in human engineered heart tissue.Am J Physiol Heart Circ Physiol2021https://conductscience.org/library/papers/33449850PubMed
934365814The Super-Relaxed State and Length Dependent Activation in Porcine Myocardium.Circ Res2021https://conductscience.org/library/papers/34365814PubMed
106214692Preparation of myosin and its subfragments from rabbit skeletal muscle.Methods Enzymol1982https://conductscience.org/library/papers/6214692PubMed
1123454346Structural and functional consequences of cardiac troponin C L57Q and I61Q Ca(2+)-desensitizing variants.Arch Biochem Biophys2013https://conductscience.org/library/papers/23454346PubMed
129147336Active and passive forces of isolated myofibrils from cardiac and fast skeletal muscle of the frog.J Physiol1997https://conductscience.org/library/papers/9147336PubMed
1327114035A Tension-Based Model Distinguishes Hypertrophic versus Dilated Cardiomyopathy.Cell2016https://conductscience.org/library/papers/27114035PubMed
1430706179Hereditary heart disease: pathophysiology, clinical presentation, and animal models of HCM, RCM, and DCM associated with mutations in cardiac myosin light chains.Pflugers Arch2019https://conductscience.org/library/papers/30706179PubMed
1528912181Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy.Circ Res2017https://conductscience.org/library/papers/28912181PubMed
1634606259Discovery of Aficamten (CK-274), a Next-Generation Cardiac Myosin Inhibitor for the Treatment of Hypertrophic Cardiomyopathy.J Med Chem2021https://conductscience.org/library/papers/34606259PubMed
1722874472Hypertrophic cardiomyopathy.Lancet2013https://conductscience.org/library/papers/22874472PubMed
1835802255Mavacamten: First Approval.Drugs2022https://conductscience.org/library/papers/35802255PubMed
1924312057Novel control of cardiac myofilament response to calcium by S-glutathionylation at specific sites of myosin binding protein C.Front Physiol2013https://conductscience.org/library/papers/24312057PubMed
2030767072Three perspectives on the molecular basis of hypercontractility caused by hypertrophic cardiomyopathy mutations.Pflugers Arch2019https://conductscience.org/library/papers/30767072PubMed

See all 38 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
42770301Mechanistic diversity within RLC-dependent myosin ATPase inhibitors differentiates EDG-7500, a diastolic-selective cardiac sarcomere modulator.JCI Insight2026https://conductscience.org/library/papers/42770301PubMed
39136654Novel cardiac myosin inhibitor for hypertrophic cardiomyopathy.J Gen Physiol2024https://conductscience.org/library/papers/39136654PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39083045

GET https://conductscience.org/api/papers/v1/39083045/references?page=2